BlackRock Fund Advisors - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 52 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q4 2016$64,000
+6.7%
58,000
+16.0%
0.00%
Q3 2016$60,000
-54.5%
50,000
-52.4%
0.00%
Q2 2016$132,000
-3.6%
105,0000.0%0.00%
Q1 2016$137,000
+3.0%
105,000
+23.5%
0.00%
Q4 2015$133,000
+15.7%
85,0000.0%0.00%
Q3 2015$115,000
-3.4%
85,0000.0%0.00%
Q2 2015$119,00085,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q2 2015
NameSharesValueWeighting ↓
Western Asset Management Company, LLC 31,076,000$29,006,00023.36%
INCOME RESEARCH & MANAGEMENT 15,589,000$14,254,0007.13%
SYMPHONY ASSET MANAGEMENT LLC 17,600,000$16,378,0005.14%
PenderFund Capital Management Ltd. 8,470,000$11,097,0003.46%
Radcliffe Capital Management, L.P. 15,823,000$14,645,0002.75%
LMR Partners LLP 34,735,000$32,172,0001.50%
Bracebridge Capital, LLC 5,500,000$5,000,0000.91%
Penn Capital Management Company, LLC 5,079,000$4,701,0000.78%
ONTARIO TEACHERS PENSION PLAN BOARD 17,400,000$16,191,0000.44%
WESTWOOD HOLDINGS GROUP INC 29,605,000$27,715,0000.42%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders